S100A4 and breast carcinoma: T47D human breast cancer cells exposed to 100 ng/ml and 500 ng/ml rhRLN2 for 72 hours also responded with a reduction in S100A4 protein (Figure 6b) with 500 ng/ml rhRLN2 already being effective after 48 hours of exposure.